Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pomalidomide-amido-C1-Br is a synthesized conjugate consisting of the Pomalidomide-based cereblon ligand and a linker, functioning as an E3 ligase ligand-linker. This compound serves as a tool for designing a B-Raf PROTAC degrader, specifically PROTAC B-Raf degrader 1, which exhibits anti-cancer activity[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 169.00 |
Description | Pomalidomide-amido-C1-Br is a synthesized conjugate consisting of the Pomalidomide-based cereblon ligand and a linker, functioning as an E3 ligase ligand-linker. This compound serves as a tool for designing a B-Raf PROTAC degrader, specifically PROTAC B-Raf degrader 1, which exhibits anti-cancer activity[1]. |
In vitro | Pomalidomide-amido-C1-Br (Compound 6) serves as a precursor for the synthesis of PROTAC B-Raf degrader 1 (Compound 2), an effective anticancer agent. It operates by inducing apoptosis in cancer cells primarily through the accelerated degradation of B-Raf, leveraging the ubiquitin-proteasome system. Furthermore, this degradation pathway impacts the expression of Mcl-1, a downstream protein associated with B-Raf, highlighting its mechanism of action[1]. |
Molecular Weight | 394.18 |
Formula | C15H12BrN3O5 |
CAS No. | 2351106-38-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pomalidomide-amido-C1-Br 2351106-38-0 Others PomalidomideamidoC1Br Pomalidomide amido C1 Br Pomalidomide-amido-C-1-Br inhibitor inhibit